These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2479359)

  • 1. Mast cell and lymphoreticular infiltrates in neurofibromas. Comparison with nerve sheath tumors.
    Johnson MD; Kamso-Pratt J; Federspiel CF; Whetsell WO
    Arch Pathol Lab Med; 1989 Nov; 113(11):1263-70. PubMed ID: 2479359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of Leu-7, myelin basic-protein, S100-protein, glial-fibrillary acidic-protein, and LN3 immunoreactivity in nerve sheath tumors and sarcomas.
    Johnson MD; Glick AD; Davis BW
    Arch Pathol Lab Med; 1988 Feb; 112(2):155-60. PubMed ID: 2447857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining for calretinin is useful for differentiating schwannomas from neurofibromas.
    Fine SW; McClain SA; Li M
    Am J Clin Pathol; 2004 Oct; 122(4):552-9. PubMed ID: 15487453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathologic characteristics of the most frequent peripheral nerve tumors].
    Coulon A; Milin S; Laban E; Debiais C; Jamet C; Goujon JM
    Neurochirurgie; 2009 Oct; 55(4-5):454-8. PubMed ID: 19744677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The controversial nosology of benign nerve sheath tumors: neurofilament protein staining demonstrates intratumoral axons in many sporadic schwannomas.
    Nascimento AF; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1363-70. PubMed ID: 17721192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells in benign nerve sheath tumours.
    Isaacson P
    J Pathol; 1976 Aug; 119(4):193-6. PubMed ID: 822142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the CD34+ cells in benign peripheral nerve sheath tumors? Double immunostaining study of CD34 and S-100 protein.
    Khalifa MA; Montgomery EA; Ismiil N; Azumi N
    Am J Clin Pathol; 2000 Jul; 114(1):123-6. PubMed ID: 10884807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic classification of peripheral nerve tumors.
    Skovronsky DM; Oberholtzer JC
    Neurosurg Clin N Am; 2004 Apr; 15(2):157-66. PubMed ID: 15177315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
    Salla JT; Johann AC; Lana AM; do Carmo MA; Nunes FD; Mesquita RA
    Oral Dis; 2008 Sep; 14(6):510-3. PubMed ID: 18826382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurinomas-neurofibromas].
    Goujon JM; Bataille B; Menet E; Lapierre F
    Neurochirurgie; 1997; 43(1):35-8. PubMed ID: 9205625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of nuclear size, ploidy, DNA histogram type and proliferation index in 79 nerve sheath tumors.
    Salmon I; Kiss R; Segers V; Carroyer JM; Levivier M; Pasteels JL; Brotchi J; Flament-Durand J
    Anticancer Res; 1992; 12(6B):2277-83. PubMed ID: 1295475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral nerve sheath tumors of the head and neck.
    Bruner JM
    Semin Diagn Pathol; 1987 May; 4(2):136-49. PubMed ID: 3313599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of nerve growth factor receptor in human benign peripheral nerve sheath tumor].
    Yasuda T; Sobue G; Hashizume Y; Mitsuma T; Takahashi A
    Rinsho Shinkeigaku; 1989 Apr; 29(4):411-20. PubMed ID: 2558831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign neural tumors of the oral cavity: a comparative immunohistochemical study.
    Chrysomali E; Papanicolaou SI; Dekker NP; Regezi JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):381-90. PubMed ID: 9347502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediastinal tumors of peripheral nervous system origin.
    Marchevsky AM
    Semin Diagn Pathol; 1999 Feb; 16(1):65-78. PubMed ID: 10355655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.
    Jokinen CH; Dadras SS; Goldblum JR; van de Rijn M; West RB; Rubin BP
    Am J Clin Pathol; 2008 Jun; 129(6):886-93. PubMed ID: 18480004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal nerve sheath tumors: an unusual cause of pelvic mass.
    Hunter VP; Burke TW; Crooks LA
    Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1050-2. PubMed ID: 3374919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actin expression in neural crest cell-derived tumors including schwannomas, malignant peripheral nerve sheath tumors, neurofibromas and melanocytic tumors.
    Dundr P; Povýsil C; Tvrdík D
    Pathol Int; 2009 Feb; 59(2):86-90. PubMed ID: 19154261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
    Nabeshima K; Iwasaki H; Nishio J; Koga K; Shishime M; Kikuchi M
    Anticancer Res; 2006; 26(2B):1359-67. PubMed ID: 16619545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.